Though the OCR levels were also decreased following CD97 knockdown, these effects were not as striking as those with ECAR and did not reach statistical significance at baseline ( Figures 3J and 3K ).
← all excerpts
The expression profile and tumorigenic mechanisms of CD97 (ADGRE5) in glioblastoma render it a targetable vulnerability.
1
—
—